Skip to main content

Table 4 Clinical Characteristics and therapy according to stroke subtypes

From: Immediate and one-year outcome of patients presenting with Acute Coronary Syndrome complicated by stroke: Findings from the 2ndGulf Registry of Acute Coronary Events (Gulf RACE-2)

 

Ischemic

Hemorrhagic

Not identified

P-value

No (%)

29(52%)

19 (34%)

8(14%)

 

Age

60.5 ± 12

60 ± 11

67 ± 15

0.41

Gender Female

10(34.5)

2(10.5)

2(25)

0.17

Diabetes Mellitus

16(52.2)

7(36.8)

1(12.5)

0.08

Hypertension

20(69)

9(47.4)

6(75)

0.23

Atrial fibrillation

4(13.8)

0(0)

0(0)

0.14

Heart rate

92 ± 19

89.9 ± 15

83 ± 30

0.54

Systolic blood pressure

132 ± 30

139 ± 35

116 ± 50

0.29

Diastolic blood pressure

76 ± 24

84 ± 19

68 ± 32

0.28

STEMI

20(69)

16(84.2)

4(50)

 

NSTEMI

6(20.7)

1(5.3)

3(37.5)

 

UA

3(0.3)

2(10.5)

1(12.5)

0.34

Coronary Angiogram

5(17.2)

1(5.3)

1(12.5)

0.30

PCI

2(6.9)

1(5.3)

0(0)

0.47

Medications on admission

    

Thrombolytic therapy

10(52.6)

5(31.2)

0(0)

0.11

Glycoprotein IIb/III inhibitors

12(41.4)

7(36.8)

6(75)

0.17

aspirin

26(89.7)

17(89.5)

8(100)

0.63

Clopidogrel

15(51.7)

6(31.6)

4(50)

0.37